Legend Biotech Corp (LEGN) Enterprise Value (2019 - 2024)
Legend Biotech (LEGN) has disclosed Enterprise Value for 6 consecutive years, with -$286.7 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Enterprise Value rose 77.57% year-over-year to -$286.7 million, compared with a TTM value of -$286.7 million through Dec 2024, up 77.57%, and an annual FY2024 reading of -$286.7 million, up 77.57% over the prior year.
- Enterprise Value was -$286.7 million for Q4 2024 at Legend Biotech, up from -$1.3 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$286.7 million in Q4 2024 and bottomed at -$1.3 billion in Q4 2023.
- Average Enterprise Value over 5 years is -$699.2 million, with a median of -$688.9 million recorded in 2021.
- The sharpest move saw Enterprise Value tumbled 446.63% in 2020, then surged 77.57% in 2024.
- Year by year, Enterprise Value stood at -$455.7 million in 2020, then crashed by 51.19% to -$688.9 million in 2021, then fell by 14.09% to -$786.0 million in 2022, then crashed by 62.64% to -$1.3 billion in 2023, then soared by 77.57% to -$286.7 million in 2024.
- Business Quant data shows Enterprise Value for LEGN at -$286.7 million in Q4 2024, -$1.3 billion in Q4 2023, and -$786.0 million in Q4 2022.